EMFAT
ALNY icon

Emerald Mutual Fund Advisers Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-832
Closed -$121K – 235
2020
Q3 		$121K Sell
832
-15
-2% -$2.13K 0.01% 254
2020
Q2 		$125K Buy
+847
New +$114K 0.01% 248
2020
Q1 		– Sell
-1,002
Closed -$115K – 224
2019
Q4 		$115K Buy
+1,002
New +$99.9K ﹤0.01% 219
2015
Q2 		– Sell
-3,964
Closed -$415K – 256
2015
Q1 		$415K Sell
3,964
-162,404
-98% -$16.5M 0.03% 198
2014
Q4 		$16.1M Sell
166,368
-45,319
-21% -$4.2M 1.4% 13
2014
Q3 		$16.5M Sell
211,687
-10,914
-5% -$704K 1.58% 8
2014
Q2 		$14.1M Buy
222,601
+9,640
+5% +$573K 1.29% 16
2014
Q1 		$14.3M Sell
212,961
-141,711
-40% -$11M 1.37% 11
2013
Q4 		$26.4M Buy
354,672
+124,595
+54% +$7.43M 1.57% 9
2013
Q3 		$14.7M Buy
230,077
+15,440
+7% +$770K 2.03% 4
2013
Q2 		$6.65M Buy
+214,637
New +$5.71M 1.13% 28

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ALNY Position: Q4 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2020, closing a stake of 832 shares — an estimated $121K sold.

Emerald Mutual Fund Advisers Trust first reported a position in ALNY in Q2 2013 and held it in 11 quarters. The position peaked at $26.4M in Q4 2013. 374 funds tracked by Wall St. Rank hold ALNY as of Q4 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Alnylam Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 832 Alnylam Pharmaceuticals shares in Q4 2020, an estimated $121K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Emerald Mutual Fund Advisers Trust's Alnylam Pharmaceuticals position peaked at $26.4M in Q4 2013.
  • 374 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2020, filed 29 Jan 2021.